Precision BioSciences, Inc. announced that Dr. Raymond Schinazi is resigning from the Board, as well as his roles as Chair of the Board's Nominating and Corporate Governance Committee and a member of the Board's Compensation Committee and Science and Technology Committee, with immediate effect. Dr. Schinazi will continue to serve on the Company's Scientific Advisory Board. Dr. Schinazi's resignation from the Board of Directors was effective as of November 5, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.73 USD | +3.29% |
|
+3.51% | -11.14% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.14% | 67.39M | |
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.25% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- DTIL Stock
- News Precision BioSciences, Inc.
- Precision BioSciences, Inc. Announces Raymond Schinazi Resigns from Board and as Chair of Nominating and Corporate Governance Committee and Member of Compensation Committee and Science and Technology Committee